AlphaFold predicted structure
PTDSS1 · P48651

Mean pLDDT
81.0/ 100
Confident
473 residues
Confidence breakdown
- Very high(≥ 90)50%
- Confident(70–90)30%
- Low(50–70)6%
- Very low(< 50)15%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
phosphatidylserine synthase 1
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
DDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownFetal anomalies
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownIntellectual disability
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedSkeletal dysplasia
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedClefting
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownLenz-Majewski hyperostotic dwarfism
neurodegenerative disease
Alzheimer disease
Parkinson disease
lysosomal storage disease
multiple sclerosis
smoking initiation
mouth disorder
hereditary disease
microcephaly
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Phosphatidylserine synthase 1
Catalyzes a base-exchange reaction in which the polar head group of phosphatidylethanolamine (PE) or phosphatidylcholine (PC) is replaced by L-serine (PubMed:19014349, PubMed:24241535). Catalyzes mainly the conversion of phosphatidylcholine (PubMed:19014349, PubMed:24241535). Also converts, in vitro and to a lesser extent, phosphatidylethanolamine (PubMed:19014349, PubMed:24241535)
PTDSS1 · P48651

Mean pLDDT
81.0/ 100
Confident
473 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0